NCOA3 is amplified and expressed in a wide spectrum of human malignancy diseases,44 and studies have demonstrated that NCOA3 promoted EMT via the PI3K/AKT signalling in gastric cancer or through SNAI1 activation in breast cancer.45, 46. Here, NCOA3 is linked to breast carcinoma.